Revised Document Posted: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012, Correction, 41190 [2012-17002]

Download as PDF pmangrum on DSK3VPTVN1PROD with NOTICES 41190 Federal Register / Vol. 77, No. 134 / Thursday, July 12, 2012 / Notices validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee for Dose Reconstruction Reviews was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. Matters To Be Discussed: The agenda for the Subcommittee meeting includes: revisiting the Board’s dose reconstruction review process; dose reconstruction program quality management and assurance activities, including an overview of contractor quality management system and an update on the results of NIOSH internal dose reconstruction blind reviews; dose reconstruction issues from NIOSH 10year review, including review of resource impact of possible changes to efficiency process and plans for a NIOSH Division of Compensation Analysis and Support claimant favorability analysis; discussion of dose reconstruction cases under review (sets 8–9, cases with Category A findings from sets 10–13, Savannah River Site cases from sets 10–13); and preselection of set 16 dose reconstruction cases to be reviewed by the Board’s technical support contractor. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30333, Telephone: (513) 533–6800, Toll Free 1 (800) CDC–INFO, Email: ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. VerDate Mar<15>2010 15:39 Jul 11, 2012 Jkt 226001 Dated: July 6, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–17041 Filed 7–11–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number NIOSH–190] Revised Document Posted: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012, Correction National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: A notice of issuance of Final Guidance Publication was published in the Federal Register June 27, 2012, (77 FR 38297). This notice is corrected as follows: AGENCY: On page 38297, the Docket number has been changed to NIOSH–190. FOR FURTHER INFORMATION CONTACT: Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS–C26, Cincinnati, OH 45226, Telephone (513) 533–8132, email hazardousdrugs@cdc.gov. Dated: July 6, 2012. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2012–17002 Filed 7–11–12; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Office of Clinical and Preventive Services Funding Opportunity: National HIV Program for Enhanced HIV/AIDS Screening and Engagement in Care Indian Health Service, HHS ACTION: Notice: correction. AGENCY: The Indian Health Service published a document in the Federal Register on June 19, 2012, concerning Announcement Type: New. Funding Announcement Number: HHS–2012– SUMMARY: PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 IHS–OCPS–HIV–0001. Catalog of Federal Domestic Assistance Number: 93.933. The document contained five incorrect dates. FOR FURTHER INFORMATION CONTACT: Dr. Charlene Avery, Director, Office of Clinical and Preventative Services, Indian Health Service, 801 Thompson Avenue, Suite 300, Reyes Building, Rockville, MD 20852, Telephone 301– 443–1190. (This is not a toll-free number.) Corrections In the Federal Register of June 19, 2012, in FR DOC 2012–14891, on page 36550, in the third column, under the heading ‘‘Dates: Key Dates:’’ ‘‘Application Deadline Date: July 16, 2012.’’ should read ‘‘July 20, 2012.’’ On page 36552, in the first column, under the heading ‘‘Proof of Non-Profit Status’’; ‘‘A copy of the 501(c)(3) Certificate must be received with your application submission by the deadline date of July 16, 2012.’’ should read ‘‘A copy of the 501(c)(3) Certificate must be received with your application submission by the deadline date of July 20, 2012.’’ On page 36553, in the first column, under the heading ‘‘3. Submission Dates and Times’’ ‘‘Applications must be submitted electronically through Grants.gov by 12:00 a.m., midnight Eastern Daylight Time (EDT) on July 16, 2012’’ should read ‘‘Applications must be submitted electronically through Grants.gov by 12:00 a.m., midnight Eastern Daylight Time (EDT) on July 20, 2012.’’ On page 36553, in the second column, under the heading ‘‘Proof of Non-Profit Status:’’ ‘‘Due Date July 16, 2012’’ should read ‘‘Due Date July 20, 2012.’’ On page 36553, in the third column, under the fourth bullet ‘‘If the waiver is approved, the application should be sent directly to the DGM by the deadline date of July 16, 2012.’’ should read ‘‘If the waiver is approved, the application should be sent directly to the DGM by the deadline date of July 20, 2012.’’ Dated: July 2, 2012. Yvette Roubideaux, Director, Indian Health Service. [FR Doc. 2012–17047 Filed 7–11–12; 8:45 am] BILLING CODE 4165–16–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Office of Urban Indian Health Programs Funding Opportunity: Title V HIV/AIDS Program AGENCY: E:\FR\FM\12JYN1.SGM Indian Health Service, HHS. 12JYN1

Agencies

[Federal Register Volume 77, Number 134 (Thursday, July 12, 2012)]
[Notices]
[Page 41190]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17002]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number NIOSH-190]


Revised Document Posted: NIOSH List of Antineoplastic and Other 
Hazardous Drugs in Healthcare Settings 2012, Correction

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: A notice of issuance of Final Guidance Publication was 
published in the Federal Register June 27, 2012, (77 FR 38297). This 
notice is corrected as follows:

-----------------------------------------------------------------------

    On page 38297, the Docket number has been changed to NIOSH-190.

FOR FURTHER INFORMATION CONTACT: Barbara MacKenzie, NIOSH, Robert A. 
Taft Laboratories, 4676 Columbia Parkway, MS-C26, Cincinnati, OH 45226, 
Telephone (513) 533-8132, email hazardousdrugs@cdc.gov.

    Dated: July 6, 2012.
John Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2012-17002 Filed 7-11-12; 8:45 am]
BILLING CODE 4163-19-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.